Skip to content
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Publication Details
AFRICAN RESEARCH NEXUS
SHINING A SPOTLIGHT ON AFRICAN RESEARCH
medicine
Implementation of primary angioplasty in Europe: Stent for Life initiative progress report
EuroIntervention, Volume 8, No. 1, Year 2012
Notification
URL copied to clipboard!
Description
Aims: Primary percutaneous coronary intervention (PPCI) is the recommended treatment for patients with acute ST-segment elevation myocardial infarction (STEMI). Despite substantial evidence of its effectiveness, a 2007 study reported that only 40-45% of European STEMI patients were treated with PPCI, with large variations in treatment availability between countries. In 2008, the Stent for Life (SFL) initiative was launched by the European Association of Percutaneous Cardiovascular Interventions and EuroPCR in partnership with the European Society of Cardiology (ESC) Working Group on Acute Cardiac Care and country-specific national cardiac societies. The aim is to promote the prioritisation of percutaneous coronary intervention treatment towards those who will benefit most, namely STEMI patients. The following countries are currently participating: Bulgaria, Egypt, France, Greece, Italy, Portugal, Romania, Serbia, Spain and Turkey. Methods and results: Since SFL was launched, several activities have been initiated in the participating countries. Preliminary reports suggest that major increases have been seen in the numbers of PPCI performed, with some countries reporting very significant increases in PPCI use from 2008-2010. Improvements in STEMI mortality rates have also been observed. Conclusions: This report summarises the progress of the SFL initiative in the 10 target countries. © Europa Edition 2012. All rights reserved.
Authors & Co-Authors
Kristensen, Steen Dalby
Denmark, Aarhus
Aarhus Universitetshospital
Fajadet, Jean C.
France, Toulouse
Clinique Pasteur
Di Mario, Carlo D.
United Kingdom, London
Royal Brompton Hospital
Kaifoszova, Zuzana
Unknown Affiliation
Laut, Kristina G.
Denmark, Aarhus
Aarhus Universitetshospital
Deleanu, Dan
Romania, Bucharest
C.c. Iliescu Institute of Cardiovascular Diseases
Gilard, Martine
France, Brest
Hopital de la Cavale Blanche
Guagliumi, Giulio
Italy, Bergamo
Ospedali Riuniti Di Bergamo
Göktekín, Ömer
Turkey, Eskisehir
Eskişehir Osmangazi Üniversitesi
Jorgova, Julia
Bulgaria, Sofia
University Hospital Alexandrovska
Kanakakis, Ioannis Georgios
Greece, Athens
National and Kapodistrian University of Athens
Ostojić, Miodrag Caslav
Serbia, Belgrade
Klinicki Centar Srbije
Pereira, He´lder Horta
Portugal, Almada
Hospital Garcia de Orta
Sabaté Tenas, Manel
Spain, Barcelona
Hospital Clinic Barcelona
Sobhy, Mohamed Ahmed
Egypt, Alexandria
Faculty of Medicine
Vrints, Christiaan J.M.
Belgium, Edegem
Universitair Ziekenhuis Antwerpen
Wijns, William C.
Belgium, Aalst
Onze Lieve Vrouw Hospital
Widimsky, Petr
Czech Republic, Prague
Charles University
Statistics
Citations: 51
Authors: 18
Affiliations: 16
Identifiers
Doi:
10.4244/EIJV8I1A7
ISSN:
1774024X
e-ISSN:
19696213
Research Areas
Noncommunicable Diseases
Study Design
Randomised Control Trial
Study Locations
Egypt